Company intelligence / Profile preview

Shanghai Minimally Invasive Heart Medical Technology

Ownership: Private
Development stage: Other

Overview

Shanghai-based companies in this sector are developing and commercializing minimally invasive devices for structural heart diseases such as mitral regurgitation and aortic stenosis. Some products have reached late-stage clinical trials or commercialization, with at least one product selected for fast-track regulatory review in China[8][4].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

No specific partnerships identified for this entity; however, similar companies often partner with hospitals/universities[8][4].

Beyond the preview

Go deeper on Shanghai Minimally Invasive Heart Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Minimally Invasive Heart Medical Technology.

Explore the full profile